Avant Technologies Inc (AVAI)

$0.48 +0.01 (2.02%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 94,600
Avg Vol 158,828
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 28%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Avant Technologies Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. Further, it offers Avant! AI, a platform that has shown impressive results related to the technology's usage, access, and performance; and InstantFAME. The company was formerly known as Trend Inn...

Industry: Software - Application
Sector: Technology
Address:
Sv. Stepono g. 27D-2, LT-01315, Vilnius, Lithuania
resx18
resx18 Aug. 18 at 6:19 PM
$AVAI adding all I can at these low prices.
0 · Reply
MatrixStocks
MatrixStocks Aug. 18 at 3:04 PM
$AVAI FDA Clinical Trial Progress Accelerates with Enhanced Recruitment: On August 12, 2025, Avant Technologies and Ainnova Tech announced a refined patient recruitment strategy for their Vision AI platform's U.S. clinical trial, targeting 1,000 multiethnic diabetic patients across 8-10 sites in community clinics.
0 · Reply
AnitaDump
AnitaDump Aug. 18 at 3:03 PM
$AVAI LETS GO !!
0 · Reply
resx18
resx18 Aug. 18 at 1:31 PM
$AVAI Avant Technologies (OTCQB: AVAI) and Ainnova Tech Bolster FDA Clinical Trial Strategy and Global Reach for Vision AI Platform FDA Clinical Trial Progress Accelerates with Enhanced Recruitment: On August 12, 2025, Avant Technologies and Ainnova Tech announced a refined patient recruitment strategy for their Vision AI platform's U.S. clinical trial, targeting 1,000 multiethnic diabetic patients across 8-10 sites in community clinics. ✅ Avant Technologies (OTCQB: $AVAI): A Rising Star in AI-Driven Healthcare Innovation Clinical Protocol Advanced Post-FDA Feedback: July 29, 2025, marked a key milestone as Ainnova revised its clinical trial protocol based on FDA input from a mid-July meeting, with resubmission imminent.
0 · Reply
resx18
resx18 Aug. 18 at 1:30 PM
$AVAI
0 · Reply
resx18
resx18 Aug. 18 at 11:29 AM
$AVAI Good article on the applications of AI in Healthcare. https://www.foreseemed.com/artificial-intelligence-in-healthcare
0 · Reply
mfay797
mfay797 Aug. 18 at 9:30 AM
$AVAI AI in healthcare is surging$
0 · Reply
LewisDaKat
LewisDaKat Aug. 13 at 12:55 AM
News Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial https://marketwirenews.com/news-releases/avant-technologies-and-ainnova-tech-announce-enhance-5674202876400104.html $AVAI
0 · Reply
BigSqueezeComing
BigSqueezeComing Aug. 12 at 12:27 PM
$AVAI Avant and Ainnova have unveiled a refined patient recruitment strategy for their upcoming FDA clinical trial targeting early detection of diabetic retinopathy using the Vision AI platform. The trial is set to be conducted at 8–10 clinical sites across the U.S., with the aim to enroll around 1,000 multiethnic diabetic patients, primarily through community clinics and primary care facilities to gather real-world data . Approval not yet granted: This update refines preparation but isn’t a regulatory milestone.
0 · Reply
BigSqueezeComing
BigSqueezeComing Aug. 12 at 12:26 PM
$AVAI https://finance.yahoo.com/news/avant-technologies-ainnova-tech-announce-120000152.html?guccounter=1
0 · Reply
Latest News on AVAI
No data available.
resx18
resx18 Aug. 18 at 6:19 PM
$AVAI adding all I can at these low prices.
0 · Reply
MatrixStocks
MatrixStocks Aug. 18 at 3:04 PM
$AVAI FDA Clinical Trial Progress Accelerates with Enhanced Recruitment: On August 12, 2025, Avant Technologies and Ainnova Tech announced a refined patient recruitment strategy for their Vision AI platform's U.S. clinical trial, targeting 1,000 multiethnic diabetic patients across 8-10 sites in community clinics.
0 · Reply
AnitaDump
AnitaDump Aug. 18 at 3:03 PM
$AVAI LETS GO !!
0 · Reply
resx18
resx18 Aug. 18 at 1:31 PM
$AVAI Avant Technologies (OTCQB: AVAI) and Ainnova Tech Bolster FDA Clinical Trial Strategy and Global Reach for Vision AI Platform FDA Clinical Trial Progress Accelerates with Enhanced Recruitment: On August 12, 2025, Avant Technologies and Ainnova Tech announced a refined patient recruitment strategy for their Vision AI platform's U.S. clinical trial, targeting 1,000 multiethnic diabetic patients across 8-10 sites in community clinics. ✅ Avant Technologies (OTCQB: $AVAI): A Rising Star in AI-Driven Healthcare Innovation Clinical Protocol Advanced Post-FDA Feedback: July 29, 2025, marked a key milestone as Ainnova revised its clinical trial protocol based on FDA input from a mid-July meeting, with resubmission imminent.
0 · Reply
resx18
resx18 Aug. 18 at 1:30 PM
$AVAI
0 · Reply
resx18
resx18 Aug. 18 at 11:29 AM
$AVAI Good article on the applications of AI in Healthcare. https://www.foreseemed.com/artificial-intelligence-in-healthcare
0 · Reply
mfay797
mfay797 Aug. 18 at 9:30 AM
$AVAI AI in healthcare is surging$
0 · Reply
LewisDaKat
LewisDaKat Aug. 13 at 12:55 AM
News Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial https://marketwirenews.com/news-releases/avant-technologies-and-ainnova-tech-announce-enhance-5674202876400104.html $AVAI
0 · Reply
BigSqueezeComing
BigSqueezeComing Aug. 12 at 12:27 PM
$AVAI Avant and Ainnova have unveiled a refined patient recruitment strategy for their upcoming FDA clinical trial targeting early detection of diabetic retinopathy using the Vision AI platform. The trial is set to be conducted at 8–10 clinical sites across the U.S., with the aim to enroll around 1,000 multiethnic diabetic patients, primarily through community clinics and primary care facilities to gather real-world data . Approval not yet granted: This update refines preparation but isn’t a regulatory milestone.
0 · Reply
BigSqueezeComing
BigSqueezeComing Aug. 12 at 12:26 PM
$AVAI https://finance.yahoo.com/news/avant-technologies-ainnova-tech-announce-120000152.html?guccounter=1
0 · Reply
MoneySwell
MoneySwell Jul. 30 at 3:10 PM
$AVAI $GEHC $HCTI $MDAI $RENB MAIGA! Making AI Great Again Again! AI Just Got a Green Light from the White House 🚀🇺🇸 https://markets.ft.com/data/announce/detail?dockey=600-202507291501PR_NEWS_USPRX____LN40065-1
0 · Reply
Sher28
Sher28 Jul. 30 at 11:55 AM
$HCTI Growth Phase @Barnabas_thehiker70 @ all the bears “NEVER” ignores facts. $HCTI isn’t where it was 6 months ago. This is next-phase growth after a full reset: ✅ Legacy dead weight cleared — toxic debt removed, no active dilutive instruments disclosed ✅ Restructured cap table — reverse split (1:249) drops float to just ~5.8M shares ✅ Revenue-generating — signed enterprise-level hospital contracts, not shanty town reviews ✅ Live AI platforms — Readeable.ai is converting clinical documents into structured data in real-time ✅ Positioned in national policy convo — featured next to $GEHC, $MDAI, $RENB, $AVAI in AI-Healthcare news tied to the White House AI plan ✅ Leadership upgrade — COO Sujatha Ramesh emphasized their move from vendor to mission-critical partner Float compression + policy tailwinds + revenue traction = this is the runway. The split isn’t the end — it’s the unlock. 🔐
0 · Reply
Sher28
Sher28 Jul. 30 at 10:51 AM
$HCTI 🧠 $HCTI just got named in a national-level AI healthcare feature alongside $GEHC, $MDAI, $AVAI, and $RENB in response to the White House’s “AI Action Plan” — yes, federal policy-level recognition. ✅ Equity Insider broke it down: • HCTI has major hospital contracts already signed • Readeable.ai is turning messy EHRs into real-time, usable clinician data • COO called it a “mission-critical partner,” not just a service provider • Direct alignment with Biden/Trump plan for AI regulation sandboxes in healthcare 🇺🇸 This is exactly the setup funds and institutional scanners watch for post-split: • AI? ✔️ • Healthcare? ✔️ • Government policy tailwind? ✔️ • Commercial traction? ✔️ And the stock’s still cheap pre-R/S. Imagine the compression post-split with PR follow-through. Big names in that article and $HCTI was one of them. Not “potential” … already being noticed and executing.
0 · Reply
stocksreports
stocksreports Jul. 29 at 11:51 AM
$RGBP $AVAI $NCNA $STRH $NBBI is making noise. After that massive run, this isn’t just another OTC pump, it’s shaping up to be a longer-term setup. Chart structure holding strong, higher highs, higher lows, and eyes on that $8 whisper. Caught my attention, watching closely for the next leg.
0 · Reply
LewisDaKat
LewisDaKat Jul. 23 at 12:25 AM
News Avant Technologies' Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference https://marketwirenews.com/news-releases/avant-technologies-joint-venture-partner-presents-ai-8622939575908486.html $AVAI
0 · Reply
jhonthemon
jhonthemon Jul. 22 at 7:34 PM
$MILIF $TWOH $ADHC $SAGMF $AVAI
0 · Reply
Ederman1
Ederman1 Jul. 22 at 2:01 PM
$AVAI https://www.gurufocus.com/news/2993312/avant-technologies-joint-venture-partner-presents-ai-technology-at-roche-ophthalmology-conference-avai-stock-news
0 · Reply
DiamondCapital
DiamondCapital Jul. 18 at 4:36 PM
New DD video covering $TWOH, $ADHC, $SAGMF, $AVAI, $MILIF,by Nicole Josephine🔥 https://x.com/stockpicksnyc/status/1946245262684324275?s=46 Link to video: https://www.youtube.com/watch?v=ayXIcmb6hwY Share the video if you’re in atleast one of these plays and subscribe to her channel for more lava hot stocks🌋
1 · Reply
StockQuen
StockQuen Jul. 17 at 7:51 PM
OTCMKTS: $AVAI Strong Buying Area it can hit $1+ Easily🔥 🚀 $AVAI x AInnova JV: $500M BOOST! 🔥 30% cheaper AI vs. AWS? ⏳ Beta Q4 2025 → Revenue 2026 $TWOH, $ADHC Watching
0 · Reply
Ederman1
Ederman1 Jul. 17 at 7:45 PM
$$AVAI Avant Technologies is pioneering the future of preventative healthcare with VisionAI—a powerful, AI-driven diagnostic platform that delivers rapid, accurate detection of diabetic retinopathy and beyond. https://finance.yahoo.com/news/artificial-intelligence-revolutionizing-early-detection-124500331.html
0 · Reply
HotStockNews
HotStockNews Jul. 17 at 4:52 PM
OTCMKTS: $AVAI We are Watching👍 Strong Fundamental Opportunity🔥 ✅JV with AInnova secured $500M financing (undisclosed institution) to deploy AI data centers. ✅BETA TESTING: Starts Q4 2025 (within months!)
0 · Reply
d_risk
d_risk Jul. 8 at 10:06 PM
$AVAI - AVANT TECHNOLOGIES INC. - 10K - Updated Risk Factors AVAI’s 2025 risk factors show improved net loss but growing deficits, extended $10M funding needs with dilution risks, removal of COVID-19 risks, and new concerns over commercialization of acquired tech and termination of Wired4Health APA. #TechnologySector #COVID-19Removal #CommercializationRisk #FundingNeeds #FinancialRisk 🟢 Added 🟠 Removed https://d-risk.ai/AVAI/10-K/2025-07-08
0 · Reply